48550 Federal Register / Vol. 71, No. 161 / Monday, August 21, 2006 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-06–06BN] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Seleda Perryman, 

CDC Assistant Reports Clearance 

Officer, 1600 Clifton Road, MS-D74, 

Atlanta, GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Conduct a Chronic Fatigue Syndrome 

Registry Pilot Test (Bibb County, 

Georgia)—New—National Center for 

Infectious Diseases (NCID) Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC is tasked with establishing a 

registry of chronic fatigue syndrome 

(CFS) and other fatiguing illnesses. The 

objective of the registry is to identify 

persons with unexplained fatiguing 

illnesses, including CFS, who access the 

healthcare system because of their 

symptoms. Patients will be between the 

ages of 12 and 59, inclusive. 

Specific aims of the registry are: (1) 

Identify and enroll patients with CFS 

and other unexplained fatiguing 

illnesses who are receiving medical and 

ancillary medical care and describe 

their epidemiologic and clinical 

characteristics; (2) follow CFS patients 

and patients with other fatiguing 

illnesses over time to characterize the 

natural history of CFS and other 

unexplained fatiguing illnesses; (3) 

assess and monitor health care 

providers’ knowledge, attitudes, and 

beliefs concerning CFS; (4) and to 

identify well-characterized CFS patients 

for clinical studies and intervention 

trials. These specific aims require 

inclusion of subjects in early stages of 

CFS (i.e., ill less than one year duration) 

who can be followed longitudinally to 

assess changes in their CFS symptoms. 

Data on persons with CFS in the general 

population has been collected in a 

separate study and is not an objective of 

this Registry. 

In order to determine the most 

effective and cost-efficient design for 

achieving the objective and specific 

aims, CDC will conduct a pilot test of 

the Registry of CFS and other fatiguing 

illnesses in Bibb County, Georgia. The 

CFS Registry Pilot Test will assess two 

Registry designs for efficacy and 

efficiency in identifying adult and 

adolescent subjects with CFS who are 

receiving medical and ancillary medical 

care. Specifically, the CFS Registry Pilot 

Test will evaluate surveillance of 

patients with CFS identified through 

physician practices and a surveillance 

of CFS patients identified by physicians 

and other health care providers. 

The proposed study will begin when 

a provider refers a patient to the 

registry. Patients who consent to be 

contacted for the registry will be asked 

to complete a detailed telephone 

interview that screens for medical and 

psychiatric eligibility. Eligible subjects 

will be invited to have a clinical 

evaluation that comprises a physical 

examination; collection of blood, urine, 

and saliva specimens; a mental health 

interview; and self-administered 

questionnaires. 

There is no cost to respondents other 

than their time. Patients who are 

clinically evaluated will be reimbursed 

for their time and effort. The total 

annualized burden hours are 2,557. 

Estimate of Annualized Burden Hours 

Respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per response 

(hours) 

Total burden 

(hours) 

Referring Providers .......................................................................................... 400 2 5/60 67 

Patient consent to be contacted ...................................................................... 677 1 10/60 113 

Patient Telephone Interview ............................................................................ 541 1 30/60 271 

Patient Clinical Evaluation ............................................................................... 234 1 540/60 2,106 

Total Burden ............................................................................................. ........................ ........................ ........................ 2,557 

Dated: August 15, 2006. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E6–13721 Filed 8–18–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: TANF Labor Market Survey. 

OMB No.: New Collection. 

Description: Understanding the 

motivations, hiring practices, and work 

place policies of employers—the 

demand side of the labor market—can 

provide considerable information to 

policy makers interested in promoting 

work and advancement among welfare 

recipients and other less-skilled 

workers. This project will add to our 

knowledge in this area by surveying 

employers in the TANF/low-wage labor 

market. We will survey a national 

sample of employers, focusing on 

industry sectors with the most jobs in 

the low-wage labor market, the 

employers most relevant for the majority 


hsrobinson on PROD1PC72 with NOTICES
Federal Register / Vol. 71, No. 161 / Monday, August 21, 2006 / Notices 48551 

of current and recent TANF recipients. 

The survey will gather information from 

employers on their attitudes, practices, 

and policies toward TANF recipient and 

other low-skill hires, including 

information on worker advancement, 

the use of work force intermediaries in 

hiring, and the role that child care plays 

in worker retention. The survey will 

allow for comparisons of employers in 

urban-core areas, suburbs, and exurbs/ 

rural areas. It will also measure 

employment outcomes for TANF 

recipients and other low-skilled 

workers, allowing us to draw 

connections between employer practices 

and employee outcomes. In short, this 

national survey of employers in the lowwage labor market can provide key 

information on what employer practices 

and policies are and how they are 

associated with workplace success for 

welfare recipients and other less-skilled 

workers. 

Respondents: A nationally 

representative sample of business 

establishments having 4 or more 

workers. 

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

TANF Labor Market Survey ............................................................................. 1,300 1 0.33 429 

Estimated Total Annual Burden 

Hours: 429. 

Additional Information: copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, 725 17th Street, NW., 

Washington, DC 20503, Attn: Desk 

Officer for ACF, E-mail address: 

Katherine_T._Astrich@omb.eop.gov. 

Dated: August 15, 2006. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 06–7036 Filed 8–18–06; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2006N–0320] 

Molecular Methods in 

Immunohematology; Public Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

The Food and Drug Administration 

(FDA) is announcing a public workshop 

entitled ‘‘Molecular Methods in 

Immunohematology.’’ The purpose of 

the public workshop is to gather and 

review current information on scientific 

developments that might enhance 

immunohematologic testing of blood 

donor or patient blood samples as part 

of pre-transfusion compatibility testing, 

or in determination and management of 

feto-maternal blood group 

incompatibilities. 

Date and Time: The public workshop 

will be held on September 25, 2006, 

from 8:30 a.m. to 5 p.m., and September 

26, 2006, from 8:30 a.m. to 2 p.m. 

Location: The public workshop will 

be held at the Lister Hill Center 

Auditorium, bldg. 38A, National 

Institutes of Health, 8800 Rockville 

Pike, Bethesda, MD 20894. 

Contact Person: Rhonda Dawson, 

Center for Biologics Evaluation and 

Research (HFM–302), Food and Drug 

Administration, 1401 Rockville Pike, 

suite 200N, Rockville, MD 20852–1448, 

301–827–6129, FAX: 301–827–2843, email: rhonda.dawson@fda.hhs.gov. 

Registration: Mail or fax your 

registration information (including 

name, title, firm name, address, 

telephone and fax numbers) to the 

contact person by September 15, 2006. 

There is no registration fee for the 

public workshop. Early registration is 

recommended because seating is 

limited. Registration on the day of the 

public workshop will be provided on a 

space available basis beginning at 8:00 

a.m. 

If you need special accommodations 

due to a disability, please contact 

Rhonda Dawson (see Contact Person) at 

least 7 days in advance of the workshop. 

SUPPLEMENTARY INFORMATION: The 

public workshop will feature 

presentations by national and 

international experts from government, 

academic institutions, and industry. The 

main goal of the workshop is to 

determine potential applications of 

molecular methods to improve safety in 

transfusion medicine by overcoming 

current limitations in the field of 

immunohematology, namely, the lack of 

reagent grade antibodies, both 

polyclonal and monoclonal; variability 

of reactivity of monoclonal antibodies as 

compared to polyclonal antibodies; and 

inherent limitations in the 

hemagglutination test. Topics to be 

discussed include the following: (1) Use 

of molecular methods in platelet and 

leukocyte typing, (2) use of phage 

display technology in place of routine 

hemagglutination tests, (3) potential 

advantages of using molecular methods 

in donor screening and patient typing, 

(4) use of molecular methods to resolve 

unusual serologic findings, (5) potential 

use of molecular methods in the 

manufacture of immunohematology 

reagents, and (6) current limitations in 

the use of molecular methods. 

Transcripts: Transcripts of the public 

workshop may be requested in writing 

from the Freedom of Information Office 

(HFI–35), Food and Drug 

Administration, 5600 Fishers Lane, rm. 

6–30, Rockville, MD 20857, 

approximately 15 working days after the 

public workshop at a cost of 10 cents 

per page. A transcript of the public 

workshop will be available on the 

Internet at http://www.fda.gov/cber/ 

minutes/workshop-min.htm. 

Dated: August 14, 2006. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E6–13695 Filed 8–18–06; 8:45 am] 

BILLING CODE 4160–01–S 


hsrobinson on PROD1PC72 with NOTICES